| Literature DB >> 31906852 |
Dadong Guo1, Meihua Ding2, Xiaoli Song3, Yuanyuan Sun3, Guoping Li2, Zonghong Li3, Huixia Wei3, Jianfeng Wu3, Wenjun Jiang4, Hongsheng Bi5.
Abstract
BACKGROUND: Myopia is one of the most common vision defects worldwide. microRNAs can regulate the target gene expression, influencing the development of diseases.Entities:
Keywords: Guinea pig; Metabolic pathway; Negative lens-induced myopia; Peroxisome proliferator-activated receptor α; microRNA profiling
Mesh:
Substances:
Year: 2020 PMID: 31906852 PMCID: PMC6945544 DOI: 10.1186/s12864-020-6447-x
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Comparison of the data of anterior chamber, crystalline lens thickness, vitreous length, axial length, and refraction before and after NLIM in guinea pigs
| LIM | Eye | Anterior chamber depth (Mean ± SEM, mm) | Crystalline lens thickness (Mean ± SEM, mm) | Vitreous length (Mean ± SEM, mm) | Axial length (Mean ± SEM, mm) | Refraction (Mean ± SEM, D) |
|---|---|---|---|---|---|---|
| Before | Fellow | 1.25 ± 0.05 | 3.39 ± 0.09 | 3.58 ± 0.17 | 8.23 ± 0. 02 | 3.15 ± 0.14 |
| NLIM | 1.27 ± 0.04 | 3.41 ± 0.11 | 3.55 ± 0.11 | 8.24 ± 0.03 | 3.23 ± 0.22 | |
| After | Fellow | 1.26 ± 0.03 | 3.61 ± 0.08 | 3.62 ± 0.14 | 8.49 ± 0.03 | 1.85 ± 0.20 |
| NLIM | 1.28 ± 0.07 | 3.63 ± 0.06 | 3.74 ± 0.12** | 8.65 ± 0.03** | −2.16 ± 0.20** |
Note: Compared with the relative NLIM fellow, **P < 0.0001. NLIM: negative lens-induced myopia
Fig. 1Alterations of the thickness of posterior sclera in normal control and NLIM guinea pigs. Quantitative analysis of the scleral thickness in both control and NLIM groups were performed (n = 6 for each group) and statistical analysis was done (lower). a = normal left eye, b = normal right eye, c = NLIM fellow eye, and d = NLIM eye. Bar = 100 μm. *P < 0.01
Fig. 2Volcano plot of differentially expressed miRNAs in NLIM sclera of guinea pigs. The red blocks are the differentially expressed miRNAs
Differentially expressed miRNAs in negative lens-induced myopia guinea pig sclera versus fellow sclera
| Mature-ID of miRNAs | Mature-sequence | Known name | Expressions |
|---|---|---|---|
| cavPor3-miR-novel-chrscaffold-107-36,268 | UAACACUGUCUGGUAAAGAUG | miR-141-3p | Up |
| cavPor3-miR-novel-chrscaffold-111-36,350 | UUGUACAUAGUAGGCUUUCAUU | miR-493-5p | Up |
| cavPor3-miR-novel-chrscaffold-4-5889 | UUGGCUCUGCGAGGUCGGCU | miR-1842 | Up |
| cavPor3-miR-novel-chrscaffold-7-7504 | CUGCGGUGAGCCUUGAAGCCU | – | Up |
| cavPor3-miR-novel-chrscaffold-111-36,469 | GAAUGUUGCUCGGUGAACCCCU | miR-409 | Up |
| cavPor3-miR-novel-chrscaffold-76-32,980 | CUAAGCCAGGGAUUGUGGGU | – | Up |
| cavPor3-miR-novel-chrscaffold-11-11,041 | UUUGGCAAUGGUAGAACUCACACU | miR-182-5p | Up |
| cavPor3-miR-novel-chrscaffold-111-36,611 | UGGAUCUUUGUCACCAGCUGAACCU | – | Up |
| cavPor3-miR-novel-chrscaffold-132-37,863 | AAUGUACCUGGGCAAGGGUUC | miR-500-3p | Up |
| cavPor3-miR-novel-chrscaffold-128-37,706 | UGUGCAAAUCCAUGCAAAACUG | miR-19b-3p | Up |
| cavPor3-miR-novel-chrscaffold-10-11,197 | UAUUGCACUCGUCCCGGCCUCC | miR-92b-3p | Down |
| cavPor3-miR-novel-chrscaffold-111-36,353 | UCCUAUAUGAUGCCUUUCCUC | rno-miR-337-3p | Down |
| cavPor3-miR-novel-chrscaffold-111-36,441 | AAUCGUACAGGGUCAUCCACUU | miR-487b-3p | Down |
| cavPor3-miR-novel-chrscaffold-15-15,154 | ACCGGGUGCUGUAGGCUU | – | Down |
| cavPor3-miR-novel-chrscaffold-12-12,421 | UGGAAUGUAAGGAAGUGUGUGG | miR-206-3p | Down |
| cavPor3-miR-novel-chrscaffold-2-2212 | GAGCAGGACGGUGGCCA | – | Down |
| cavPor3-miR-novel-chrscaffold-119-37,316 | UGGAAUGUAAAGAAGUGUGUAU | miR-1-3p | Down |
| cavPor3-miR-novel-chrscaffold-111-36,472 | UGGUCGACCAGUUGGAAAGU | miR-412-5p | Down |
| cavPor3-miR-novel-chrscaffold-68-31,730 | GUGCAUGAUGACAACUG | miR-1341 | Down |
| cavPor3-miR-novel-chrscaffold-84-33,871 | UGAUUGCAUCCUCUGAGGGAGA | – | Down |
| cavPor3-miR-novel-chrscaffold-128-37,724 | CAAAACGUGAGGCGCUGCUAU | rno-miR-322-3p | Down |
| cavPor3-miR-novel-chrscaffold-120-37,436 | AAUGUGUAGCAGAAGACAGACU | rno-miR-511-3p | Down |
| cavPor3-miR-novel-chrscaffold-46-27,908 | AAUGGCGCCACUAGGGUUGUGA | miR-652-3p | Down |
| cavPor3-miR-novel-chrscaffold-27-20,777 | ACAGUAGUCUGCACAUUGGUU | miR-199a-3p | Down |
| cavPor3-miR-novel-chrscaffold-13-13,335 | UUGGCCUACAGAAGUGACAGAC | – | Down |
| cavPor3-miR-novel-chrscaffold-84-33,870 | CAACUCCAGGAUUCGUCGAUC | – | Down |
| cavPor3-miR-novel-chrscaffold-26-19,738 | UUAUAAUACAACCUGAUAAGU | miR-374a-5p | Down |
Fig. 3Validation of differentially expressed miRNAs in NLIM guinea pig sclera by using quantitative PCR technique. Triplicate assays were performed for each RNA sample and the relative amount of each miRNA was normalized to 5S RNA. Statistically significant difference between NLIM eyes and fellow subjects was presented by *P < 0.05 (n = 6). 13,335 = cavPor3-miR-novel-chrscaffold-13-13,335,7436 = cavPor3-miR-novel-chrscaffold-120-37,436,37,316 = cavPor3-miR-novel-chrscaffold-119-37,316,37,706 = cavPor3-miR-novel-chrscaffold-128-37,706,36,268 = cavPor3-miR-novel-chrscaffold-107-36,268,32,980 = cavPor3-miR-novel-chrscaffold-76-32,980
Fig. 4Annotations of differentially expressed microRNAs by GO annotation. Categorization of microRNA-targeted genes was performed according to the biological process and molecular function. The digit in the bracket is the number of the target genes for differentially expressed miRNAs
Primer sequences for differentially expressed miRNAs determined by quantitative PCR
| Target gene name | Primers |
|---|---|
| 5S rRNA | F: 5’TCTCGTCTGATCTCGGAAGC3’ |
| R: 5’GCGGTCTCCCATCCAAGTA3’ | |
| cavPor3-miR-novel-chrscaffold-13-13,335 | GSP: 5’CGATTCGTTGGCCTACAGAAGTG3’ |
| R: 5’ATCCAGTGCAGGGTCCGAGG3’ | |
| cavPor3-miR-novel-chrscaffold-120-37,436 | GSP: 5’CGCTCCGAATGTGTAGCAGAAGA3’ |
| R: 5’ATCCAGTGCAGGGTCCGAGG3’ | |
| cavPor3-miR-novel-chrscaffold-119-37,316 | GSP: 5’GGGGGTGGAATGTAAAGAAGT3’ |
| R: 5’GTGCGTGTCGTGGAGTCG3’ | |
| cavPor3-miR-novel-chrscaffold-128-37,706 | GSP: 5’GGGGTTGTGCAAATCCATG3’ |
| R: 5’GTGCGTGTCGTGGAGTCG3’ | |
| cavPor3-miR-novel-chrscaffold-107-36,268 | GSP: 5’CGCCATCGTAACACTGTCTGGTA3’ |
| R: 5’ATCCAGTGCAGGGTCCGAGG3’ | |
| cavPor3-miR-novel-chrscaffold-76-32,980 | GSP: 5’CGACATTGCCTAAGCCAGGGATT3’ |
| R: 5’ATCCAGTGCAGGGTCCGAGG3’ |
GSP is the specific primer which is matched to target gene; R is the primer that is matched to reverse transcription primer (R)
Fig. 5KEGG pathway enrichment analysis based on mRNAs targeted by differentially expressed miRNAs. Top ten signaling pathways are listed by the categorization
PPAR α primer sequences for quantitative PCR
| Gene name | Primers |
|---|---|
| β-actin | F: 5′ ACCCCAAGGCCAACCGTGAGAAGATG 3’ |
| R: 5′ CTCGGCCGTGGTGGTGAAACTGTAGC3’ | |
| PPAR α | F: 5′ TCAAAAACCTCCGCAAACCCTTCT 3’ |
| R: 5′ GGCCGATCTCCGCAGCAAATGA 3’ |
Fig. 6Determination of PPAR α at mRNA and protein levels in normal control and NLIM guinea pig sclera. Using pooled samples, quantitative PCR (a) and western blotting (b) analyses were done, and histogram analysis was carried out for western blotting (c). Data were presented as mean ± SD for mRNA and protein expressions (n = 6 for each group) and *P < 0.05
Fig. 7miR-novel-chrscaffold-128-37,706 targeted PPAR α. (a) the sequence of 3′-UTR where PPAR α mRNA bound to miR-novel-chrscaffold-128-37,706; (b) dual-luciferase reporter gene assay, which showed that miR-novel-chrscaffold-128-37,706 mimics could inhibit the luciferase activity of miR-novel-chrscaffold-128-37,706/PPAR α-WT plasmid. However, it had no effect on the luciferase activity of miR-novel-chrscaffold-128-37,706/PPAR α-MT. *P < 0.05; WT, wild type; MT, mutant type
Fig. 8General design and workflow of the experiment. The determination at each stage includes normal control and negative lens-induced myopia (NLIM) groups, and each group contains six guinea pigs